Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fenretinide in Treating Patients With Leukoplakia of the Mouth

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Alabama at Birmingham Identifier:
First received: December 10, 1999
Last updated: April 10, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2004
  Primary Completion Date: January 2004 (Final data collection date for primary outcome measure)